breast cancer

Dr. April Rose has joined the JGH as Attending Staff in the Division of Medical Oncology and in the Segal Cancer Centre.

Dr. William Foulkes, an expert in cancer genetics and a senior investigator at the Lady Davis Institute, has received the 2020 Wilder Penfield Prize for his research.

Three surgeons have been newly appointed at the JGH in Colorectal Surgery, General Surgery and Neurosurgery.

Dr. Mark Basik, a surgical oncologist at the JGH and a senior investigator in the Lady Davis Institute, has been appointed President of the Scientific Advisory Committee of the Cancer Research Society.

Approximately 3,011 people streamed through the streets of Montreal in August 2005 in the first Weekend to End Breast Cancer, giving a major boost to the treatment and prevention of breast cancer at the Segal Cancer Centre.

Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been chosen to serve as one of two leaders of a new Canada-wide team, aimed at translating fundamental research about breast cancer into effective treatment options for patients.

When significant events or noteworthy achievements occur within the CIUSSS West-Central Montreal, they often receive wide coverage by news media. Here’s a sampling of some recent stories.

One of Hope & Cope’s newest initiatives, the Breast & Bone Health Program, identifies women who have had breast cancer and are at risk for bone fragility.

It is unjustified and potentially harmful to screen women for genes whose connection to breast cancer has yet to be proven, says an international team of leading geneticists and oncologists.

Dr. Roderick McInnes, Director of the Lady Davis Institute at the JGH, has received the 2015 Award for Excellence in Human Genetics Education from the American Society of Human Genetics.